CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
XTL BIopharmaceuticals Limited Company Snapshot
XTL BIopharmaceuticals Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares XTL BIopharmaceuticals Limited with three other pharmaceutical manufacturers in Middle East: Compugen Ltd (2013 sales of 12.78 million Israel Shekels [US$3.63 million] of which 100% was Biological Research), Rosetta Genomics Ltd. (USA) (1.46 million Israel Shekels [US$414,771.14 ] ), and Solegreen Ltd (3.77 million Israel Shekels [US$1.07 million] ).

Sales Analysis.
   
   
 
  Stock Performance Chart for XTL BIopharmaceuticals Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (11/16/2017): .09
(Figures in Israel Shekels)
1 Week 10.1%   13 Weeks -3.3%  
4 Weeks -15.5%   52 Weeks -42.8%  
 
XTL BIopharmaceuticals Limited Key Data:
  Ticker: XTLB Country: Israel
  Exchanges: OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2013 Sales 8,530,485
(Year Ending Jan 2014).
Employees: 6
  Currency: Israel Shekels Market Cap: 23,855,905
  Fiscal Yr Ends: December Shares Outstanding: 274,205,799
  Share Type: Ordinary Closely Held Shares: 164,412,114
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.